knowledge -WSS

knowledge

author：fashion 2025-10-01 23:02:13 - browse：9

What difference does a day make? Who gets to have gene therapy? And are biotech startups OK?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to explain how the approval of a landmark gene therapy for Duchenne muscular dystrophy set in motion a frantic race to get children treated before their 6th birthdays. Then, HSBC Managing Director Jonathan Norris calls in to discuss why so many biotech startups are facing financial bridges to nowhere.

For more on what we cover, here’s the story on gene therapy; here’s more on Ipsen’s treatment for FOP; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： CRISPR technology availability, affordability needs to be expanded

WSS

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Bring on the sabbaticals for nurses

Pregnancy ages women, but effects reverse after delivery

Bring on the sabbaticals for nurses

What is artificial intelligence? Experts weigh in

What Kate Middleton's cancer revelation might teach the world

Wikipedia

knowledge

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medical devices makers are asking for forgiveness, not permission

Guidelines to prevent youth baseball injuries need more muscle

'Patient friction coefficient' can gauge a clinical trial's patient burden

Virginia high school admissions case could be legal follow

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

DIEP, the 'gold standard' of breast reconstruction, is under threat

Biden White House, tech companies launch new safeguards around emerging AI technology

Walensky prepares to leave CDC — and Congress — behind

Mirador, a new biotech startup, launches with $400 million

leisure time

Prosecutors say FTX founder Sam Bankman

Bring on the sabbaticals for nurses

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Erich Jarvis studies song birds to learn about human stuttering

CRISPR technology availability, affordability needs to be expanded

What Kate Middleton's cancer revelation might teach the world

explore

leisure time

focus

focus